Dopamine manipulations limited to preexposure are sufficient to modulate latent inhibition

Behavioral Neuroscience

Volumn 120, Issue 3, 2006, Pages 554-562

  Bethus, I ^a,c   Muscat, R ^b   Goodall, G ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b UNIVERSITY OF MALTA   (Malta)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Amphetamine; Dopamine; Haloperidol; Latent inhibition; Preexposure

Indexed keywords

AMPHETAMINE; DOPAMINE; HALOPERIDOL;

ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONDITIONING; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; EXPOSURE; LATENT INHIBITION; MALE; NONHUMAN; RAT; REINFORCEMENT; TASTE AVERSION;

AMPHETAMINE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, CLASSICAL; CONDITIONING, OPERANT; DOPAMINE; DOPAMINE ANTAGONISTS; DRINKING BEHAVIOR; DRUG ADMINISTRATION SCHEDULE; HALOPERIDOL; INHIBITION (PSYCHOLOGY); MALE; RATS;

EID: 33745892426     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.120.3.554     Document Type: Article

References (38)

1. Barrett, R. J., Caul, W. F., & Smith, R. (2005). Withdrawal, tolerance, and sensitization to dopamine mediated interoceptive cues in rats trained on a three-lever drug-discrimination task. Pharmacology, Biochemistry and Behavior, 81, 1-8.
2. Bassareo, V., De Luca, M. A., & Di Chiara, G. (2002). Differential expression of motivational stimulus properties by dopamine in nucleus accumbens shell versus core and prefrontal cortex. Journal of Neuroscience, 22, 4709-4719.
3. Dieu, Y., Seillier, A., Majchrzak, M., Marchand, A., & Di Scala, G. (2005). Systemic or intra-accumbens injection of D-amphetamine delays habituation to a tone stimulus in rats. Behavioural Pharmacology, 16, 35-42.
4. Ellenbroek, B. A., Knobbout, D. A., & Cools, A. R. (1997). The role of mesolimbic and nigrostriatal dopamine in latent inhibition as measured with the conditioned taste aversion paradigm. Psychopharmacology (Berl), 129, 112-120.
5. Escobar, M., Oberling, P., & Miller, R. R. (2002). Associative deficit accounts of disrupted latent inhibition and blocking in schizophrenia. Neuroscience and Biobehavioral Reviews, 26, 203-216.
6. Gray, J. A., Feldon, J., Rawlins, J. N. P., Hemsley, D. R., Dawling, S., & Smith, A. D. (1991). The neuropsychology of schizophrenia. Behavioral Brain Science, 14, 1-20.
7. Gray, J. A., Joseph, M. H., Hemsley, D. R., Young, A. M., Warburton, E. C., Boulenguez, P., et al. (1995). The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: Implications for schizophrenia. Behavioural Brain Research, 71, 19-31.
8. Joseph, M. H., Peters, S. L., & Gray, J. A. (1993). Nicotine blocks latent inhibition in rats: Evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure. Psychopharmacology (Berl), 110, 187-192.
9. Joseph, M. H., Peters, S. L., Moran, P. M., Grigoryan, G. A., Young, A. M., & Gray, J. A. (2000). Modulation of latent inhibition in the rat by altered dopamine transmission in the nucleus accumbens at the time of conditioning. Neuroscience, 101, 921-930.
10. Kapur, S. (2003). Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia. American Journal of Psychiatry, 160, 13-23.
11. Killcross, A. S., Dickinson, A., & Robbins, T. W. (1994). Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: Implications for animal models of schizophrenic attentional dysfunction. Psychopharmacology (Berl), 115, 185-195.
12. Killcross, A. S., Stanhope, K. J., Dourish, C. T., & Piras, G. (1997). WAY100635 and latent inhibition in the rat: Selective effects at preexposure. Behavioural Brain Research, 88, 51-57.
13. Lubow, R. E. (1989). Latent inhibition and conditioned attention theory. New York: Cambridge University Press.
14. Lubow, R. E. (2005). Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia. Schizophrenia Bulletin, 31, 139-153.
15. Mackintosh, N. J. (1975). A theory of attention: Variations in the associability of stimuli with reinforcement. Psychological Review, 82, 276-298.
16. Moser, P. C., Hitchcock, J. M., Lister, S., & Moran, P. M. (2000). The pharmacology of latent inhibition as an animal model of schizophrenia. Brain Research Reviews, 33, 275-307.
17. Peters, S. L., & Joseph, M. H. (1993). Haloperidol potentiation of latent inhibition in rats: Evidence for a critical role at conditioning rather than pre-exposure. Behavioural Pharmacology, 4, 183-186.
18. Rochford, J., Sen, A. P., & Quirion, R. (1996). Effect of nicotine and nicotinic receptor agonists on latent inhibition in the rat. Journal of Pharmacology and Experimental Therapeutics, 277, 1267-1275.
19. Russig, H., Kovacevic, A., Murphy, C. A., & Feldon, J. (2003). Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion. Psychopharmacology (Berl), 170, 263-270.
20. Russig, H., Murphy, C. A., & Feldon, J. (2002). Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal. Neuropsychopharmacology, 26, 765-777.
21. Sammut, S., Bethus, I., Goodall, G., & Muscat, R. (2002). Antidepressant reversal of interferon-alpha-induced anhedonia. Physiology and Behavior, 75, 765-772.
22. Schmajuk, N. A., Gray, J. A., & Larrauri, J. A. (2005). A pre-clinical study showing how dopaminergic drugs administered during pre-exposure can impair or facilitate latent inhibition. Psychopharmacology (Berl), 177, 272-279.
23. Shadach, E., Gaisler, I., Schiller, D., & Weiner, I. (2000). The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin. Neuropsychopharmacology, 23, 151-161.
24. Solomon, P. R., Crider, A., Winkelman, J. W., Turi, A., Kamer, R. M., & Kaplan, L. J. (1981). Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: Relationship to schizophrenic attention disorder. Biological Psychiatry, 16, 519-537.
25. Solomon, P. R., & Staton, D. M. (1982). Differential effects of microinjections of D-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus. Biological Psychiatry, 17, 743-756.
26. Stadler, J. R., Caul, W. F., & Barrett, R. J. (1999). Characterizing withdrawal in rats following repeated drug administration using an amphetamine-vehicle-haloperidol drug discrimination. Psychopharmacology (Berl), 143, 219-226.
27. Warburton, E. C., Joseph, M. H., Feldon, J., Weiner, I., & Gray, J. A. (1994). Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: Implications for a possible antipsychotic action of ondansetron. Psychopharmacology (Berl), 114, 657-664.
28. Weiner, I. (1990). Neural substrates of latent inhibition: The switching model. Psychological Bulletin, 108, 442-461.
29. Weiner, I., & Feldon, J. (1987). Facilitation of latent inhibition by haloperidol in rats. Psychopharmacology (Berl), 91, 248-253.
30. Weiner, I., & Feldon, J. (1997). The switching model of latent inhibition: An update of neural substrates. Behavioural Brain Research, 88, 11-25.
31. Weiner, I., Feldon, J., & Katz, Y. (1987). Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats. Pharmacology, Biochemistry and Behavior, 26, 241-246.
32. Weiner, I., Izraeli-Telerant, A., & Feldon, J. (1987). Latent inhibition is not affected by acute or chronic administration of 6 mg/kg D-amphetamine. Psychopharmacology (Berl), 91, 345-351.
33. Weiner, I., Kidron, R., Tarrasch, R., Arnt, J., & Feldon, J. (1994). The effects of the new antipsychotic, sertindole, on latent inhibition in rats. Behavioural Pharmacology, 5, 119-124.
34. Weiner, I., Lubow, R. E., & Feldon, J. (1984). Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology (Berl), 83, 194-199.
35. Weiner, I., Lubow, R. E., & Feldon, J. (1988). Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacology, Biochemistry and Behavior, 30, 871-878.
36. Weiner, I., Schiller, D., Gaisler-Salomon, I., Green, A., & Joel, D. (2003). A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine. Behavioural Pharmacology, 14, 215-222.
37. Weiner, I., Shadach, E., Tarrasch, R., Kidron, R., & Feldon, J. (1996). The latent inhibition model of schizophrenia: Further validation using the atypical neuroleptic, clozapine. Biological Psychiatry, 40, 834-843.
38. Wise, R. A. (2004). Dopamine, learning and motivation. National Review of Neuroscience, 5, 483-494.